Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm

被引：237

作者：

Haberer, Jessica E. ^{[1
,2
]}

Bangsberg, David R. ^{[1
,2
]}

Baeten, Jared M. ^{[3
,4
]}

Curran, Kathryn ^{[5
]}

Koechlin, Florence ^{[5
]}

Amico, K. Rivet ^{[6
]}

Anderson, Peter ^{[7
]}

Mugo, Nelly ^{[3
,8
]}

Venter, Francois ^{[9
]}

Goicochea, Pedro ^{[10
,11
]}

Caceres, Carlos ^{[11
,12
]}

O'Reilly, Kevin ^{[5
]}

机构：

[1] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA

[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA

[3] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA

[4] Univ Washington, Dept Med, Seattle, WA USA

[5] WHO, CH-1211 Geneva, Switzerland

[6] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA

[7] Univ Colorado, Dept Pharmaceut Sci, Denver, CO 80202 USA

[8] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya

[9] WITS Reprod Hlth & HIV Inst, Johannesburg, South Africa

[10] Univ Calif San Francisco, San Francisco, CA 94143 USA

[11] Network Multidisciplinary Studies ARV Based HIV P, Lima, Peru

[12] Univ Peruana Cayetano Heredia, Lima, Peru

来源：

AIDS | 2015年 / 29卷 / 11期

基金：

美国国家卫生研究院;

关键词：

ACTIVE ANTIRETROVIRAL THERAPY; LESS-THAN; 95-PERCENT; TRANSGENDER WOMEN; INHIBITOR THERAPY; INFECTED ADULTS; SUPPRESSION; TRIAL; MEN; TRANSMISSION; INTERMITTENT;

D O I：

10.1097/QAD.0000000000000647

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1277 / 1285

页数：9

共 50 条

[1] Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence
Haberer, Jessica E.
Kidoguchi, Lara
Heffron, Renee
Mugo, Nelly
Bukusi, Elizabeth
Katabira, Elly
Asiimwe, Stephen
Thomas, Katherine K.
Celum, Connie
Baeten, Jared M.
[J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20
[2] Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting
Montgomery, Madeline C.
Oldenburg, Catherine E.
Nunn, Amy S.
Mena, Leandro
Anderson, Peter
Liegler, Teri
Mayer, Kenneth H.
Patel, Rupa
Almonte, Alexi
Chan, Philip A.
[J]. PLOS ONE, 2016, 11 (06):
[3] Pre-exposure prophylaxis for HIV prevention: how to predict success
Kashuba, Angela D. M.
Patterson, Kristine B.
Dumond, Julie B.
Cohen, Myron S.
[J]. LANCET, 2012, 379 (9835): : 2409 - 2411
[4] PRE-EXPOSURE PROPHYLAXIS FOR HIV PREVENTION
Cremin, I.
Hallett, T.
Dybul, M.
Piot, P.
Garnett, G.
[J]. SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 : A36 - A36
[5] HIV prevention trial design in an era of effective pre-exposure prophylaxis
Cutrell, Amy
Donnell, Deborah
Dunn, David T.
Glidden, David V.
Grobler, Anneke
Hanscom, Brett
Stancil, Britt S.
Meyer, R. Daniel
Wang, Ronnie
Cuffe, Robert L.
[J]. HIV CLINICAL TRIALS, 2017, 18 (5-6): : 177 - 188
[6] Pre-exposure prophylaxis as HIV prevention in the UK
Brady, Michael
[J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (03) : 150 - 152
[7] HIV prevention using pre-exposure prophylaxis
Daou, S.
Calmy, A.
[J]. REVUE DE MEDECINE INTERNE, 2011, 32 (11): : 658 - 662
[8] PrEP: pre-exposure prophylaxis for HIV prevention
Page, Matthew
Nicholls, Jane
[J]. TRENDS IN UROLOGY & MENS HEALTH, 2018, 9 (04) : 22 - 24
[9] Oral pre-exposure prophylaxis for HIV prevention
Garcia-Lerma, J. Gerardo
Paxton, Lynn
Kilmarx, Peter H.
Heneine, Walid
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (02) : 74 - 81
[10] HIV pre-exposure prophylaxis: effective and underused
Hempel, Amanda
Biondi, Mia J.
Baril, Jean-Guy
Tan, Darrell H. S.
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (45) : E1544 - E1550

← 1 2 3 4 5 →